Cargando…

Multiparametric Analysis of Cell-Free DNA in Melanoma Patients

Cell-free DNA in blood (cfDNA) represents a promising biomarker for cancer diagnosis. Total cfDNA concentration showed a scarce discriminatory power between patients and controls. A higher specificity in cancer diagnosis can be achieved by detecting tumor specific alterations in cfDNA, such as DNA i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvianti, Francesca, Pinzani, Pamela, Verderio, Paolo, Ciniselli, Chiara Maura, Massi, Daniela, De Giorgi, Vincenzo, Grazzini, Marta, Pazzagli, Mario, Orlando, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507877/ https://www.ncbi.nlm.nih.gov/pubmed/23209607 http://dx.doi.org/10.1371/journal.pone.0049843

Ejemplares similares

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method
por: Mazzini, Cinzia, et al.
Publicado: (2014)

Data and performances evaluation of the SPIDIA-DNA Pan-European External Quality Assessment: 2nd SPIDIA-DNA laboratory report
por: Malentacchi, Francesca, et al.
Publicado: (2016)

Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing
por: Salvianti, Francesca, et al.
Publicado: (2015)

SPIDIA-RNA: Second External Quality Assessment for the Pre-Analytical Phase of Blood Samples Used for RNA Based Analyses
por: Malentacchi, Francesca, et al.
Publicado: (2014)

Analytical Evaluation of an NGS Testing Method for Routine Molecular Diagnostics on Melanoma Formalin-Fixed, Paraffin-Embedded Tumor-Derived DNA
por: Mancini, Irene, et al.
Publicado: (2019)

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study
por: Salvianti, Francesca, et al.
Publicado: (2021)

Developing miRNA signatures: a multivariate prospective
por: Verderio, Paolo, et al.
Publicado: (2016)

Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer
por: De Luca, Francesca, et al.
Publicado: (2016)

Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification
por: Salvianti, Francesca, et al.
Publicado: (2017)

Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data
por: Sala, Laura, et al.
Publicado: (2022)

3Rs Principle and Legislative Decrees to Achieve High Standard of Animal Research
por: Verderio, Paolo, et al.
Publicado: (2023)

Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
por: Mascalchi, Mario, et al.
Publicado: (2017)

New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
por: Salvianti, Francesca, et al.
Publicado: (2017)

Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients
por: De Logu, Francesco, et al.
Publicado: (2021)

A Particularly Bothersome Umbilical Nodule
por: Rossari, Susanna, et al.
Publicado: (2013)

COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center
por: Ciniselli, Chiara Maura, et al.
Publicado: (2022)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)
por: Mandalà, Mario, et al.
Publicado: (2020)

Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients
por: Fina, Emanuela, et al.
Publicado: (2022)

Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study
por: Cantini, Giulia, et al.
Publicado: (2020)

Hereditary colorectal cancer syndromes and the COVID-19 pandemic: results from a survey conducted in patients enrolled in a dedicated registry
por: Signoroni, Stefano, et al.
Publicado: (2021)

Monitoring Vitamin B(12) in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic Diseases
por: Mastroianni, Antonio, et al.
Publicado: (2019)

SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region
por: Ciniselli, Chiara Maura, et al.
Publicado: (2021)

Corrigendum to “Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)” [Eur J Canc 137 (2020). Pages 30–39]
por: Mandalà, Mario, et al.
Publicado: (2020)

Melanoma brain metastases: review of histopathological features and immune-molecular aspects
por: Salvati, Lorenzo, et al.
Publicado: (2020)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
por: Gandellini, Paolo, et al.
Publicado: (2021)

Prevalence and Management of Cancer of the Rectal Stump after Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study
por: Colletti, Gaia, et al.
Publicado: (2022)

Reply to Serrano et al. Comment on “Colletti et al. Prevalence and Management of Cancer of the Rectal Stump after Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study. Cancers 2022, 14, 298”
por: Colletti, Gaia, et al.
Publicado: (2022)

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals
por: Gatti, Laura, et al.
Publicado: (2014)

Conceptual Evolution and Current Approach to Spitz Tumors
por: Urso, Carmelo, et al.
Publicado: (2022)

Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended
por: Giussani, Marta, et al.
Publicado: (2021)

The TRPA1 Channel Amplifies the Oxidative Stress Signal in Melanoma
por: De Logu, Francesco, et al.
Publicado: (2021)

Management of Dietary Habits and Diarrhea in Fap Individuals: A Mediterranean Low-Inflammatory Dietary Intervention
por: Maura, Ciniselli Chiara, et al.
Publicado: (2021)

Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid‐type fibromatosis
por: Zanchetta, Edoardo, et al.
Publicado: (2021)

Biomarkers for Monitoring Pre-Analytical Quality Variation of mRNA in Blood Samples
por: Zhang, Hui, et al.
Publicado: (2014)

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
por: Colombino, Maria, et al.
Publicado: (2013)

Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review
por: Indini, Alice, et al.
Publicado: (2021)

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma
por: El Bezawy, Rihan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6svv2hc9pqb82v99n1or09tkon